銀禧科技(300221.SZ):以1551.851萬元競得珠海市一宗三類工業用地
格隆匯3月2日丨銀禧科技(300221.SZ)公佈,公司子公司蘇州銀禧科技及銀禧工塑在珠海高欄港經濟區共同設立子公司珠海銀禧科技有限公司(以下簡稱“珠海銀禧科技”)為承擔“銀禧新材料珠海生產基地建設項目”建設,參與珠海市公共資源交易中心組織的珠海市國有建設用地使用權網上掛牌出讓競拍,以1551.851萬元競得了交易序號為“22004”地塊的國有土地使用權,並於近日與珠海市自然資源局簽署了《珠海市公共資源交易中心成交確認書》。
地塊位置為珠海市金灣區南水鎮石油化工區石化五路西北側、興海路西南側。土地用途為三類工業用地;准入產業類別:化學原料及化學制品製造業(其他合誠材料製造)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.